MYUNGMOON Pharm co.,Ltd 017180.KS Stock
MYUNGMOON Pharm co.,Ltd Price Chart
MYUNGMOON Pharm co.,Ltd 017180.KS Financial and Trading Overview
MYUNGMOON Pharm co.,Ltd stock price | 2055 KRW |
Previous Close | 2670 KRW |
Open | 2670 KRW |
Bid | 2635 KRW x 0 |
Ask | 2645 KRW x 0 |
Day's Range | 2630 - 2690 KRW |
52 Week Range | 2270 - 3555 KRW |
Volume | 41.22K KRW |
Avg. Volume | 65.33K KRW |
Market Cap | 89.25B KRW |
Beta (5Y Monthly) | 0.56678 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 27, 2017 |
1y Target Est | N/A |
017180.KS Valuation Measures
Enterprise Value | 167.51B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.5661543 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.063 |
Enterprise Value/EBITDA | 13.332 |
Trading Information
MYUNGMOON Pharm co.,Ltd Stock Price History
Beta (5Y Monthly) | 0.56678 |
52-Week Change | -19.090% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3555 KRW |
52 Week Low | 2270 KRW |
50-Day Moving Average | 2639.9 KRW |
200-Day Moving Average | 2699.75 KRW |
017180.KS Share Statistics
Avg. Volume (3 month) | 65.33K KRW |
Avg. Daily Volume (10-Days) | 69.68K KRW |
Shares Outstanding | 33.81M |
Float | 26.66M |
Short Ratio | N/A |
% Held by Insiders | 21.92% |
% Held by Institutions | 0.61% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1.020921:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 4.74% |
Operating Margin (ttm) | 5.30% |
Gross Margin | 53.35% |
EBITDA Margin | 7.96% |
Management Effectiveness
Return on Assets (ttm) | 2.29% |
Return on Equity (ttm) | 8.18% |
Income Statement
Revenue (ttm) | 157.64B KRW |
Revenue Per Share (ttm) | 4645.17 KRW |
Quarterly Revenue Growth (yoy) | 16.00% |
Gross Profit (ttm) | N/A |
EBITDA | 12.56B KRW |
Net Income Avi to Common (ttm) | 7.49B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | -39.60% |
Balance Sheet
Total Cash (mrq) | 10.91B KRW |
Total Cash Per Share (mrq) | 322.71 KRW |
Total Debt (mrq) | 82.62B KRW |
Total Debt/Equity (mrq) | 86.38 KRW |
Current Ratio (mrq) | 0.675 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 4.61B KRW |
Levered Free Cash Flow (ttm) | 835.05M KRW |
Profile of MYUNGMOON Pharm co.,Ltd
Country | South Korea |
State | N/A |
City | Seoul |
Address | 7, Gangnam-daero |
ZIP | 06258 |
Phone | 82 2 6711 2000 |
Website | https://www.mmpharm.co.kr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 289 |
MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, fillers, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, oral disease products, antidiarrheal agents, digestive system products, cold drugs, calcium products, nasal sprays, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.
Q&A For MYUNGMOON Pharm co.,Ltd Stock
What is a current 017180.KS stock price?
MYUNGMOON Pharm co.,Ltd 017180.KS stock price today per share is 2055 KRW.
How to purchase MYUNGMOON Pharm co.,Ltd stock?
You can buy 017180.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MYUNGMOON Pharm co.,Ltd?
The stock symbol or ticker of MYUNGMOON Pharm co.,Ltd is 017180.KS.
Which industry does the MYUNGMOON Pharm co.,Ltd company belong to?
The MYUNGMOON Pharm co.,Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does MYUNGMOON Pharm co.,Ltd have in circulation?
The max supply of MYUNGMOON Pharm co.,Ltd shares is 33.53M.
What is MYUNGMOON Pharm co.,Ltd Price to Earnings Ratio (PE Ratio)?
MYUNGMOON Pharm co.,Ltd PE Ratio is now.
What was MYUNGMOON Pharm co.,Ltd earnings per share over the trailing 12 months (TTM)?
MYUNGMOON Pharm co.,Ltd EPS is 0 KRW over the trailing 12 months.
Which sector does the MYUNGMOON Pharm co.,Ltd company belong to?
The MYUNGMOON Pharm co.,Ltd sector is Healthcare.